Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 27, 2015 - Issue 14
558
Views
23
CrossRef citations to date
0
Altmetric
Review Article

Respiratory effects of sulfur mustard exposure, similarities and differences with asthma and COPD

, &
Pages 731-744 | Received 14 Jul 2015, Accepted 25 Oct 2015, Published online: 04 Dec 2015

References

  • Afshinniaz F, Ghanei M. (1995). Relationship of the chronic respiratory symptoms with spirometric and laboratory parameters [dissertation]. Isfahan, Iran: Isfahan University of Medical Sciences
  • Aghanouri R, Ghanei M, Aslani J, et al. (2004). Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 287:L1160–4
  • Allon N, Amir A, Manisterski E, et al. (2009). Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicol Appl Pharm 241:154–62
  • Amini M, Oghabian Z. (2013). Late-onset radiologic findings of respiratory system following sulfur mustard exposure. Asia Pac J Med Toxicol 2:58–62
  • Amir A, Chapman S, Kadar T, et al. (2000). Sulfur mustard toxicity in macrophages: effect of dexamethasone. J Appl Toxicol 20:S51–8
  • Anderson DR, Holmes WW, Lee RB, et al. (2006) Sulfur mustard-induced neutropenia: treatment with granulocyte colony-stimulating factor. DTIC Document
  • Anderson DR, Taylor SL, Fetterer DP, Holmes WW. (2009). Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury. Toxicology 263:41–6
  • Anderson DR, Yourick JJ, Moeller RB, et al. (1996). Pathologic changes in rat lungs following acute sulfur mustard inhalation. Inhal Toxicol 8:285–97
  • Angelini DJ, Dorsey RM, Willis KL, et al. (2013). Chemical warfare agent and biological toxin-induced pulmonary toxicity: could stem cells provide potential therapies? Inhal Toxicol 25:37–62
  • Arredouani M, Matthijs P, Van Hoeyveld E, et al. (2003). Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 108:144–51
  • Aslani J. (2000). Late respiratory complications of sulfur mustard. In: Cheraghali AM (ed.) Prevention and treatment of complications of chemical warfare agents. Tehran, Iran: Chemical Warfare Research Centrr; pp. 76–9
  • Attaran D, Lari SM, Khajehdaluee M, et al. (2009). Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Hum Exp Toxicol 28:739–45
  • Bahadori M, Pishva N, Masjedi M. (1989). History of pulmonary lesions in victims of chemical warfare. Ir J Med Sci 14:999–1005
  • Balali-Mood M, Hefazi M. (2006). Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99:273–82
  • Balali-Mood M, Hefazi M, Mahmoudi M, et al. (2005). Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 19:713–21
  • Beheshti J, Mark EJ, Akbaei HMH, et al. (2006). Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 202:739–44
  • Bijani K, Moghadamnia A. (2002). Long-term effects of chemical weapons on respiratory tract in Iraq–Iran war victims living in Babol (North of Iran). Ecotoxicol Environ Saf 53:422–4
  • Black R, Clarke R, Harrison J, Read RW. (1997). Biological fate of sulphur mustard: identification of valine and histidine adducts in haemoglobin from casualties of sulphur mustard poisoning. Xenobiotica 27:499–512
  • Boskabady M, Boskabady MH, Zabihi NA, Boskabady M. (2012). The effect of chemical warfare on respiratory symptoms, pulmonary function tests and their reversibility 23–25 years after exposure. Toxicol Ind Health 31:79–84
  • Boskabady MH, Amery S, Vahedi N, Khakzad MR. (2011a). The effect of vitamin E on tracheal responsiveness and lung inflammation in sulfur mustard exposed guinea pigs. Inhal Toxicol 23:157–65
  • Boskabady MH, Attaran D, Shaffei MN. (2008). Airway responses to salbutamol after exposure to chemical warfare. Respirology 13:288–93
  • Boskabady MH, Farhadi J. (2008). The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med 14:1137–44
  • Boskabady MH, Saadatinejad M. (2003). Airway responsiveness to beta-adrenergic agonist (salbutamol) in asthma. J Asthma 40:917–25
  • Boskabady MH, Tabatabayee A, Amiri S, Vahedi N. (2011b). The effect of vitamin E on pathological changes in kidney and liver of sulphur mustard-exposed guinea pigs. Toxicol Ind Health 28:216–21
  • Boskabady MH, Vahedi N, Amery S, Khakzad MR. (2011c). The effect of Nigella sativa alone, and in combination with dexamethasone, on tracheal muscle responsiveness and lung inflammation in sulfur mustard exposed guinea pigs. J Ethnopharmacol 137:1028–34
  • Brent J. (2005). Critical care toxicology: diagnosis and management of the critically poisoned patient. Philadelphia, PA: Mosby
  • Calvet J-H, Jarreau P-H, Levame M, et al. (1994a). Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pig. J Appl Physiol 76:681–88
  • Calvet J-H, Planus E, Rouet P, et al. (1999). Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am J Physiol Lung Cell Mol Physiol 276:L754–62
  • Calvet J, d'Ortho M, Jarreau P, et al. (1994b). Glucocorticoids inhibit sulfur mustard-induced airway muscle hyperresponsiveness to substance P. J Appl Physiol 77:2325–32
  • Car BD, Meloni F, Luisetti M, et al. (1994). Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149:655–59
  • Chakrabarti S, Patel KD. (2005). Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res 31:599–621
  • Chan A, Allen R. (2004). Bronchiolitis obliterans: an update. Curr Opin Pulm Med 10:133–41
  • Chatterjee D, Mukherjee S, Smith MG, Das SK. (2003). Signal transduction events in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J Biochem Mol Toxicol 17:114–21
  • Chen Z-H, Kim HP, Sciurba FC, et al. (2008). Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One 3:e3316
  • Corbel M, Belleguic C, Boichot E, Lagente V. (2002). Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 18:51–61
  • Cowan FM, Anderson DR, Broomfield CA, et al. (1997). Biochemical alterations in rat lung lavage fluid following acute sulfur mustard inhalation: II. Increases in proteolytic activity. Inhal Toxicol 9:53–61
  • Debiak M, Kehe K, Bürkle A. (2009). Role of poly(ADP-ribose) polymerase in sulfur mustard toxicity. Toxicology 263:20–5
  • Eklöw L, Moldéus P, Orrenius S. (1984). Oxidation of glutathione during hydroperoxide metabolism. Eur J Biochem 138:459–63
  • Emad A, Emad Y. (2007). Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J Interferon Cytokine Res 27:38–43
  • Emad A, Emad Y. (2008). Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis. J Clin Immunol 28:298–305
  • Emad A, Rezaian G, Hosseini K, Ghayyoomi S. (1995). Chronic pulmonary sequelae of sulfur mustard gas exposure in man: a report of 36 Cases. Irn J Med Sci 20:1–4
  • Emad A, Rezaian GR. (1997). The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest J 112:734–38
  • Emad A, Rezaian GR. (1999). Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest J 115:1346–51
  • Evison D, Hinsley D, Rice P. (2002). Regular review: chemical weapons. BMJ 324:332–5
  • Feister AJ. (1991). Medical defense against mustard gas: toxic mechanisms and pharmacological implications. Boca Raton, FL: CRC Press
  • Foroutan S. (1997). Medical notes on the chemical warfare: Part II (in Persian). Kowsar Med J 1:159–77
  • Freitag L, Firusian N, Stamatis G, Greschuchna D. (1991). The role of bronchoscopy in pulmonary complications due to mustard gas inhalation. Chest J 100:1436–41
  • Gao X, Ray R, Xiao Y, et al. (2010). Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. Pulm Pharmacol Ther 23:97–106
  • Gao X, Ray R, Xiao Y, Ray P. (2008). Suppression of inducible nitric oxide synthase expression and nitric oxide production by macrolide antibiotics in sulfur mustard-exposed airway epithelial cells. Basic Clin Pharmacol Toxicol 103:255–61
  • Gautam A, Singh S, Kulkarni A, et al. (2005). Protective effect of Aloe vera L. gel against sulphur mustard-induced systemic toxicity and skin lesions. Indian J Pharmacol 87:103–10
  • Ghanei M, Adibi I, Farhat F, Aslani J. (2008). Late respiratory effects of sulfur mustard: how is the early symptoms severity involved? Chron Respir Dis 5:95–100
  • Ghanei M, Akhlaghpoor S, Moahammad MM, Aslani J. (2004). Tracheobronchial stenosis following sulfur mustard inhalation. Inhal Toxicol 16:845–49
  • Ghanei M, Harandi AA. (2007). Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19:451–56
  • Ghanei M, Khalili ARH, Arab MJ, et al. (2005). Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 97:302–5
  • Ghannadpour S. (1986) Studies on the biochemical factors of people exposed to sulfur mustard. Tehran: Tarbiat Modares University Press
  • Ghasemi H, Ghazanfari T, Yaraee R, et al. (2009). Evaluation of relationship between the serum levels of inflammatory mediators and ocular injuries induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1494–98
  • Ghazanfari T, Sharifnia Z, Yaraee R, et al. (2009). Serum soluble Fas ligand and nitric oxide in long-term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1489–93
  • Gholamnezhad ZBM, Amery S, Vahedi N, et al. (2015). The effect of vitamin E on lung pathology in sulfur mustard exposed guinea pigs. Toxicol Ind Health Sep 17 [Epub ahead of print]
  • Goven D, Boutten A, Lecon-Malas V, et al. (2009). Prolonged cigarette smoke exposure decreases heme oxygenase-1 and alters Nrf2 and Bach1 expression in human macrophages: roles of the MAP kinases ERK(1/2) and JNK. FEBS Lett 583:3508–18
  • Gregory TJ, Steinberg KP, Spragg R, et al. (1997). Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155:1309–15
  • Guignabert C, Taysse L, Calvet J-H, et al. (2005). Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am J Physiol Lung Cell Mol Physiol 289:L67–74
  • Hassan ZM, Ebtekar M. (2002). Immunological consequence of sulfur mustard exposure. Immunol Lett 83:151–2
  • van Helden HP, Kuijpers WC, Diemel RV. (2004). Asthma like symptoms following intratracheal exposure of guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal Toxicol 16:537–48
  • Hosseini-khalili A, Haines DD, Modirian E, et al. (2009). Mustard gas exposure and carcinogenesis of lung. Mutat Res-Gen Tox En 678:1–6
  • Hosseini K, Moradi A, Mansouri A, Vessal K. (1989). Pulmonary manifestations of mustard gas injury: a review of 61 cases. Iran J Med Sci 14:20–6
  • Kabir SM, Mukherjee S, Rajaratnam V, et al. (2009). Desensitization of beta-adrenergic receptors in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J Biochem Mol Toxicol 23:59–70
  • Keatings VM, Collins PD, Scott DM, Barnes PJ. (1996). Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153:530–4
  • Kehe K, Balszuweit F, Steinritz D, Thiermann H. (2009a). Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology 263:12–19
  • Kehe K, Szinicz L. (2005). Medical aspects of sulphur mustard poisoning. Toxicology 214:198–209
  • Kehe K, Thiermann H, Balszuweit F, et al. (2009b). Acute effects of sulfur mustard injury-Munich experiences. Toxicology 263:3–8
  • Keshmiri M. (1989). Pulmonary cause of death from chemical warfare agents: the Halabche experience. Iran J Med Sci 14:10–19
  • Khateri S, Ghanei M, Keshavarz S, et al. (2003). Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45:1136–43
  • Korkmaz A, Kunak ZI, Paredes SD, et al. (2008). The use of melatonin to combat mustard toxicity. Review. Neuro Endocrinol Lett 29:614–19
  • Korkmaz A, Yaren H, Topal T, Oter S. (2006). Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch Toxicol 80:662–70
  • Kumar O, Sugendran K, Vijayaraghavan R. (2001). Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem Biol Interact 134:1–12
  • Lagente V, Manoury B, Nenan S, et al. (2005). Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res 38:1521–30
  • Langenberg JP, van der Schans GP, Spruit HE, et al. (1998). Toxicokinetics of sulfur mustard and its DNA-adducts in the hairless guinea pig. Drug Chem Toxicol 21:131–47
  • Laohaburanakit P, Chan A, Allen RP. (2003). Bronchiolitis obliterans. Clin Rev Allergy Immunol 25:259–74
  • Laskin DLGC, Laskin JD. (2010). Phagocytes. In: Lawrence D (ed.) Comprehensive toxicology, 2nd ed. Immune system toxicology. Vol. 5. London, UK: Elsevier, 133–53
  • Lee T-M, Lin M-S, Chang N-C. (2008). Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 101:530–5
  • Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M. (2005). Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol 5:1479–85
  • Malaviya R, Sunil VR, Cervelli J, et al. (2010). Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol Appl Pharmacol 248:89–99
  • Matsui A, Yokoo H, Negishi Y, et al. (2012). CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80-cells and promotes tumor progression. PLoS One 7:e44080
  • Mattos W, Lim S, Russell R, et al. (2002). Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest J 122:1543–52
  • Mautino G, Oliver N, Chanez P, et al. (1997). Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 17:583–91
  • McClintock SD, Hoesel LM, Das SK, et al. (2006). Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 26:126–31
  • McClintock SD, Till GO, Smith MG, Ward PA. (2002). Protection from half-mustard-gas-induced acute lung injury in the rat. J Appl Toxicol 22:257–62
  • Mehrani H, Ghanei M, Aslani J, Golmanesh L. (2009). Bronchoalveolar lavage fluid proteomic patterns of sulfur mustard-exposed patients. Proteomics Clin Appl 3:1191–200
  • Mehrani H, Ghanei M, Aslani J, Tabatabaei Z. (2011). Plasma proteomic profile of sulfur mustard exposed lung diseases patients using 2-dimensional gel electrophoresis. Clin Proteomics 8:2. DOI: 10.1186/1559-0275-8-2
  • Mirsadraee M, Attaran D, Boskabady M, Towhidi M. (2005). Airway hyperresponsiveness to methacholine in chemical warfare victims. Respiration 72:523–8
  • Mishra NC, Rir-sima-ah J, Grotendorst GR, et al. (2012). Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology. Int Immunopharmacol 13:101–8
  • Mishra NC, Rir-sima-ah J, March T, et al. (2010). Sulfur mustard induces immune sensitization in hairless guinea pigs. Int Immunopharmacol 10:193–99
  • Mood MB, Afshari R, Zojaji R, et al. (2010). Delayed toxic effects of sulfur mustard on respiratory tract of Iranian veterans. Hum Exp Toxicol 30:1141–9
  • Mroz BJ, Sexauer WP, Meade A, Balsara G. (1997). Hemoptysis as the presenting symptom in bronchiolitis obliterans organizing pneumonia. Chest J 111:1775–8
  • Mukhopadhyay S, Hoidal JR, Mukherjee TK. (2006). Role of TNFalpha in pulmonary pathophysiology. Respir Res 7:125
  • Mukhopadhyay S, Mukherjee S, Smith M, Das SK. (2008). Activation of MAPK/AP-1 signaling pathway in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard gas analog. Toxicol Lett 181:112–17
  • Najafi A, Masoudi-Nejad A, Ghanei M, et al. (2014). Pathway reconstruction of airway remodeling in chronic lung diseases: a systems biology approach. PLoS One 9:e100094
  • Nishimoto Y, Burrows B, Miyanishi M, et al. (1970). Chronic obstructive lung disease in Japanese poison gas workers. Am Rev Respir Dis 102:173–9
  • O'Rourke MA, Feussner JR, Feigl P, Laszlo J. (1987). Age trends of lung cancer stage at diagnosis: implications for lung cancer screening in the elderly. JAMA 258:921–6
  • Ohbayashi H. (2002). Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 3:409–21
  • Ohno I, Ohtani H, Nitta Y, et al. (1997). Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 16:212–19
  • Pirzad G, Jafari M, Tavana S, et al. (2011). The role of Fas-FasL signaling pathway in induction of apoptosis in patients with sulfur mustard-induced chronic bronchiolitis. J Toxicol 2010:1–7
  • Pohl C, Papritz M, Moisch M, et al. (2009). Acute morphological and toxicological effects in a human bronchial coculture model after sulphur mustard exposure. Toxicol Sci 112:482–9
  • Pourfarzam S, Ghazanfari T, Yaraee R, et al. (2009). Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1482–8
  • Randolph DA, Stephens R, Carruthers CJ, Chaplin DD. (1999). Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 104:1021–9
  • Ray R, Keyser B, Benton B, et al. (2008). Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells: evidence of a dominant caspase-8-mediated pathway and differential cellular responses. Drug Chem Toxicol 31:137–48
  • Ray R, Simbulan-Rosenthal CM, Keyser BM, et al. (2010). Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. Toxicology 271:94–9
  • Rowell M, Kehe K, Balszuweit F, Thiermann H. (2009). The chronic effects of sulfur mustard exposure. Toxicology 263:9–11
  • Roy SS, Mukherjee S, Kabir S, et al. (2005). Inhibition of cholinephosphotransferase activity in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J Biochem Mol Toxicol 19:289–97
  • Saber H, Saburi A, Ghanei M. (2012). Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside. Inhal Toxicol 24:900–6
  • Sapey E, Stockley R. (2006). COPD exacerbations. 2: Aetiology. Thorax 61:250–8
  • Seagrave J, Weber WM, Grotendorst GR. (2010). Sulfur mustard vapor effects on differentiated human lung cells. Inhal Toxicol 22:896–902
  • Selek S, Cosar N, Kocyigit A, et al. (2008). PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin Biochem 41:140–4
  • Seo T, Pahwa P, McDuffie HH, et al. (2008). Interactive effect of paraoxonase-1 Q192R polymorphism and smoking history on the lung function decline in grain workers. Ann Epidemiol 18:330–4
  • Shakarjian MP, Heck DE, Gray JP, et al. (2010). Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci 114:5–19
  • Shohrati M, Ghanei M, Shamspour N, et al. (2010). Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 188:77–83
  • Shohrati M, Ghanei M, Shamspour N, Jafari M. (2008). Activity and function in lung injuries due to sulphur mustard. Biomarkers 13:728–33
  • Shohrati M, Hosseini RH, Esfandiari MA, et al. (2014). Serum matrix metalloproteinase levels in patients exposed to sulfur mustard. Iran Red Crescent Med J 16:e15129
  • Sidell F. (1990). Clinical notes on chemical casualty care. Army Training Pamphlet USAMRICD TM90-1
  • Sin DD, Man SP. (2008). Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. Curr Opin Pulm Med 14:115–21
  • Sohrabpour H. (1984). Clinical manifestations of chemical agents on Iranian combatants during Iran-Iraq conflict. Arch Belg Suppl:291–7
  • Somani S, Babu S. (1989). Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 27:419–35
  • Sourdeval M, Lemaire C, Deniaud A, et al. (2006). Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis 11:1545–59
  • Stepanov A, Popov V. (1962). Chemical weapons and principles of antichemical defense. Translated by Joint Publications Research Service JPRS 15107. Washengton, DC: JPRS
  • Sunil V, Patel K, Malaviya R, et al. (2009). Inflammatory mediator expression in the lung following exposure to the sulfur mustard analog, 2-chloroethyl ethyl sulfide; role of TNFR1. Am J Respir Crit Care Med 179:A5863
  • Sunil VR, Patel KJ, Shen J, et al. (2011). Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard. Toxicol Appl Pharmacol 250:10–18
  • Sutherland E, Martin RJ. (2003). Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol 112:819–27
  • Takayuki S, Pahwa P, McDuffie HH, et al. (2007). Association between paraoxonase-1 Q192R polymorphism and lung function among Saskatchewan grain handlers. Pharmacogenomics 8:901–8
  • Taravati A, Ardestani SK, Soroush M-R, et al. (2012). Serum albumin and paraoxonase activity in Iranian veterans 20 years after sulfur mustard exposure. Immunopharmacol Immunotoxicol 34:706–13
  • Tekes S, Isik B, Yildiz T, et al. (2010). Chronic obstructive pulmonary disease and paraoxonase-1 192 and 55 gene polymorphisms. Biotechnol Biotechnol 24:1644–7
  • Thomason JW, Rice TW, Milstone AP. (2003). Bronchiolitis obliterans in a survivor of a chemical weapons attack. JAMA 290:598–99
  • Tschumperlin DJ, Drazen JM. (2001). Mechanical stimuli to airway remodeling. Am J Respir Crit Care Med 164:S90–4
  • Vahedi E, Taheri S, Alaedini F, et al. (2012). Correlations of sleep disorders with severity of obstructive airway disease in mustard gas-injured patients. Sleep Breath 16:443–51
  • Vignola AM, Riccobono L, Mirabella A, et al. (1998). Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 158:1945–50
  • Warner J, Julius P, Luttmann W, Kroegel C. (1997). Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge. Int Arch Allergy Immunol 113:318–20
  • Weber WM, Kracko DA, Lehman MR, et al. (2010). Inhalation exposure systems for the development of rodent models of sulfur mustard-induced pulmonary injury. Toxicol Mech Methods 20:14–24
  • Wigenstam E, Rocksén D, Ekstrand-Hammarström B, Bucht A. (2009). Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal Toxicol 21:958–64
  • Willems-Widyastuti A, Alagappan VK, Arulmani U, et al. (2011). Transforming growth factor-1 induces angiogenesis in vitro via VEGF production in human airway smooth muscle cells. Indian J Biochem Biophys 48:262–9
  • Willems J. (1989). Clinical management of mustard gas casualties. Ann Med Mil Belg 3:1–61
  • Willemse B, Postma D, Timens W, Ten Hacken N. (2004). The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 23:464–76
  • Yanbaeva DG, Dentener MA, Spruit MA, et al. (2009). IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med Genet 10:23
  • Yaraee R, Ghazanfari T, Ebtekar M, et al. (2009a). Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1466–70
  • Yaraee R, Ghazanfari T, Faghihzadeh S, et al. (2009b). Alterations in the serum levels of soluble L, P and E-selectin 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1477–81
  • Yaren H, Mollaoglu H, Kurt B, et al. (2007). Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res Vet Sci 83:116–22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.